Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials.
about
A safety assessment of biological therapies targeting the IL-23/IL-17 axis in inflammatory bowel diseases.Cardiometabolic Disorders in Psoriatic Disease.A reply to: 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials'.Psoriasis and Cardiovascular Comorbidities: Focusing on Severe Vascular Events, Cardiovascular Risk Factors and Implications for Treatment.Next generation of biologics for the treatment of Crohn's disease: an evidence-based review on ustekinumab.Endothelial function is impaired in the cutaneous microcirculation of adults with psoriasis through reductions in nitric oxide-dependent vasodilation.Safety of biologics in psoriasis.Reply to 'Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials': reply from the authors.Comorbidities in Spondyloarthritis.Potential Immunological Links Between Psoriasis and Cardiovascular Disease.Secukinumab in the treatment of psoriatic arthritis: efficacy and safety results through 3 years from the year 1 extension of the randomised phase III FUTURE 1 trialPsoriasis, Cardiovascular Events, and Biologics: Lights and Shadows
P2860
Q38749257-8BA5E05D-8245-4E14-88C5-509FC44E3E0EQ40069191-5AFC7CE3-A28C-47AA-BD1E-525BA9AB80C2Q46025484-BC411141-2DA1-4CDD-B2E1-2DAE12DC64A0Q46180528-AA130E63-197C-4852-8BB9-263DBE8B65E7Q47141159-40B10B63-0AF5-4E93-B34F-D9C3CD1C107CQ47750772-B9A3ABB0-0CFB-46DF-A800-27407C65B3FAQ48144965-F3CA9419-4127-4DA8-A748-604F554D34F4Q49488482-5CFBF08E-EADE-459E-991B-E4C266A6C3A5Q54246292-0FC177C4-C9CA-4BA3-9421-907ED0AE4894Q55270893-82FED507-ECA2-4621-B3BF-62DAD7DD68E4Q57169747-3CD8D05F-E4E6-4214-8233-4F7483667045Q58785751-A2EF290F-AAF4-40F4-8A04-BB6DADE2AE6B
P2860
Impact of biologic therapies on risk of major adverse cardiovascular events in patients with psoriasis: systematic review and meta-analysis of randomized controlled trials.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Impact of biologic therapies o ...... randomized controlled trials.
@ast
Impact of biologic therapies o ...... randomized controlled trials.
@en
type
label
Impact of biologic therapies o ...... randomized controlled trials.
@ast
Impact of biologic therapies o ...... randomized controlled trials.
@en
prefLabel
Impact of biologic therapies o ...... randomized controlled trials.
@ast
Impact of biologic therapies o ...... randomized controlled trials.
@en
P2860
P31
P50
P356
P1476
Impact of biologic therapies o ...... randomized controlled trials.
@en
P2093
R B Warren
W Rungapiromnan
P2860
P304
P356
10.1111/BJD.14964
P407
P5008
P577
2016-08-12T00:00:00Z
2017-04-01T00:00:00Z